Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, May 2008

Sort by: Newest first Oldest first A-Z Z-A

  • David Leitch Keir (Death notice) Subscription

    24 MAY 2008

    On 9 May 2008, David Leitch Keir, aged 91, of Woodlands, off Glasgow Road, Perth PH2 0PJ.Mr Keir registered in 1941 and retired from the Register in 2004. 

  • Drug interactions that can occur with statins and macrolide antibacterials Subscription

    24 MAY 2008

    An elderly woman with a history of hyperlipidaemia and hypertension presents with a fast heart rate, and new-onset atrial fibrillation (AF) is diagnosed. Initial therapy with a beta blocker fails to control the AF, so diltiazem is prescribed. Aspirin is also started, and the patient’s usual medication of ramipril 5mg daily and simvastatin 40mg daily is continued.

  • Disciplinary Committee inquiries Subscription

    24 MAY 2008

    The Disciplinary Committee will meet at the Royal Pharmaceutical Society of Great Britain on Tuesday 27, Wednesday 28 and Thursday 29 May 2008 at 9.30am to hear the following matters:

  • Erasure from the Register on the direction of the Statutory Committee Subscription

    24 MAY 2008

    The name of the following person was erased from the Register of Pharmaceutical Chemists on 14 May 2008 following the direction of the Statutory Committee at its meeting on 14 February 2008: Christopher Dotchin (registration number 1051544), of Newcastle upon Tyne.Jeremy HolmesChief Executive and Registrar

  • Interferon (Phillip A. Harrington, Peter Arnold Inc/Science Photo Library)

    Interferon was not the miracle cure for cancer hoped for in its early days Subscription

    24 MAY 2008 11:05

    In the eighth article in a series on landmark drugs, Jenny Bryan looks at the early history of interferon. Although it failed to provide a cure for cancer, its success in other areas, such as multiple sclerosis and hepatitis, will feature in the next article in the series  

  • Intracerebral haemorrhage: severe disability not reduced by rFVIIa

    Treatment with haemostatic agent does not improve stroke survival

    24 MAY 2008 9:44

    Therapy with the haemostatic agent recombinant activated factor VII (rFVIIa) reduces haematoma growth but does not improve survival or reduce severe disability after intracerebral haemorrhage, findings of a phase III trial show.

  • Chronic diseases overtaking infectious diseases, says WHO

    24 MAY 2008 9:44

    Chronic conditions, such as heart disease and stroke, are overtaking infectious diseases like tuberculosis and malaria as the main causes of death across the world, according to new statistics published by the World Health Organization this week (May 2008).

  • New alliance to improve access to affordable drugs in developing countries

    24 MAY 2008 9:44

    The Medicines Transparency Alliance, which aims to contribute to increased access to affordable essential medicines in developing countries in co-operation with pharmaceutical companies, was launched last week (May 2008).

  • Pharmacist independent prescribing may improve antibiotic use

    24 MAY 2008 9:44

    Prudent use of antibiotics will increase as more pharmacists qualify as independent prescribers, a group of MPs, healthcare professionals and patient group and industry representatives were told this week (May 2008).

  • Avian influenza virus particles

    Pre-pandemic bird flu vaccine approved for Europe

    24 MAY 2008 9:43

    This week (May 2008) the first marketing authorisation for an H5N1 pre-pandemic vaccine for humans — GlaxoSmithKline’s Prepandrix — has been granted by the European Commission.

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.